Results 121 to 130 of about 74,519 (261)
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
British Journal of Clinical Pharmacology, EarlyView.Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić +4 more
wiley +1 more source
U.S. Healthcare Insurance Market Concentration from 2001 to 2016: Increased Growth in Direct Written Premiums and Overall Decreased Market Consolidation. [PDF]
Cureus, 2020 Ng MK +10 more
europepmc +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
British Journal of Clinical Pharmacology, EarlyView.The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
TRENDS AND PROBLEMS IN THE CONTEMPORARY DEVELOPMENT OF THE INSURANCE MARKET OF RUSSIA
Научный вестник МГТУ ГА, 2016 The article reveals features and tendencies of development of the Russian insurance market, indicators of development of the insurance market of Russia are analyzed.
N. I. Zakharova +2 more
doaj
Global trends in the insurance market and the functioning of the insurance market in Serbia
Strategic Management, 2014 During 2010 , the insurance sector globally managed to overcome the effects of the economic crisis, with re-growth of insurance premiums especially in some economies, particularly in the life insurance sector, positive returns on investment, and certainly, associated with it, to strengthen the position of solvency.
openaire +1 more source
British Journal of Clinical Pharmacology, EarlyView.Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer +4 more
wiley +1 more source
LIBERALIZATION AND MARKET CONCENTRATION IN THE INSURANCE INDUSTRY: CASE OF CROATIA
Economic Review, 2011 This paper analyzes market concentration on the market of insurance companies in Croatia. For a very long time, Croatian insurance market was dominated by one company.
Lorena Škuflić +2 more
doaj
PERFORMANCES OF THE ROMANIAN INSURANCE MARKET [PDF]
Annals of the University of Petrosani: Economics, 2013 Global crisis affected the worldwide insurance market differently from one country to another, so Romanian insurance market in the period between 2008 and 2012 was also affected by global crisis. Effectiveness and performance of the insurance market from Romania is discussed in the paper based on the statistical data published by the Insurance ...
openaire +1 more source
British Journal of Clinical Pharmacology, EarlyView.Study design and main findings. After 1:1 propensity score matching, 60 885 PCSK9 inhibitor users and 60 885 statin‐only users with ASCVD were compared. Kaplan–Meier curves show 12‐month cumulative event‐free survival for MACE, psychiatric disease, and neurodegenerative disease.
Tianshu Gu +7 more
wiley +1 more source